HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Haotian Zhang Selected Research

maleimide

9/2018In situ low-immunogenic albumin-conjugating-corona guiding nanoparticles for tumor-targeting chemotherapy.
8/2018In vivo tailor-made protein corona of a prodrug-based nanoassembly fabricated by redox dual-sensitive paclitaxel prodrug for the superselective treatment of breast cancer.
1/2018Striking a Balance between Carbonate/Carbamate Linkage Bond- and Reduction-Sensitive Disulfide Bond-Bearing Linker for Tailored Controlled Release: In Situ Covalent-Albumin-Binding Gemcitabine Prodrugs Promote Bioavailability and Tumor Accumulation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Haotian Zhang Research Topics

Disease

48Neoplasms (Cancer)
06/2022 - 08/2014
10Neoplasm Metastasis (Metastasis)
02/2022 - 10/2018
9Breast Neoplasms (Breast Cancer)
01/2022 - 11/2017
5Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
11/2021 - 01/2019
4Ischemic Stroke
02/2022 - 01/2020
3Brain Ischemia (Cerebral Ischemia)
02/2022 - 01/2019
3Circulating Neoplastic Cells
10/2021 - 01/2019
2Obesity
11/2022 - 06/2020
2Stroke (Strokes)
02/2022 - 10/2021
2Thrombosis (Thrombus)
01/2022 - 01/2020
2Pneumonia (Pneumonitis)
01/2021 - 10/2019
2Hepatocellular Carcinoma (Hepatoma)
01/2017 - 03/2016
1Chronobiology Disorders (Circadian Rhythm Disorder)
11/2022
1Sarcoma (Soft Tissue Sarcoma)
06/2022
1Osteosarcoma (Osteogenic Sarcoma)
06/2022
1Melanoma (Melanoma, Malignant)
01/2022
1Hemorrhage
01/2022
1Necrosis
01/2022
1Osteoarthritis
01/2022
1Cytokine Release Syndrome
01/2022
1Atrophy
11/2021
1Brain Edema (Cerebral Edema)
10/2021
1Infarction (Infarctions)
10/2021
1Thromboinflammation
10/2021
1Transient Ischemic Attack
10/2021

Drug/Important Bio-Agent (IBA)

14Pharmaceutical PreparationsIBA
02/2022 - 12/2014
13ProdrugsIBA
01/2022 - 11/2017
6Photosensitizing Agents (Photosensitizers)IBA
08/2021 - 09/2018
5pseudoginsenoside F11 (PF 11)IBA
02/2022 - 10/2019
5DisulfidesIBA
09/2020 - 11/2017
4Neuroprotective AgentsIBA
02/2022 - 01/2020
4Doxorubicin (Adriamycin)FDA LinkGeneric
01/2022 - 10/2019
4Paclitaxel (Taxol)FDA LinkGeneric
01/2022 - 08/2018
4ocotillolIBA
10/2021 - 10/2019
41-phenyl-3,3-dimethyltriazene (PDT)IBA
08/2021 - 01/2019
4Proteins (Proteins, Gene)FDA Link
01/2020 - 01/2017
4AlbuminsIBA
10/2019 - 01/2018
3Biomarkers (Surrogate Marker)IBA
06/2022 - 01/2017
3Reactive Oxygen Species (Oxygen Radicals)IBA
01/2022 - 01/2019
3Immune Checkpoint InhibitorsIBA
01/2022 - 01/2021
3SaponinsIBA
10/2021 - 10/2019
3Coloring Agents (Dyes)IBA
09/2021 - 10/2018
3LipidsIBA
06/2020 - 11/2015
3EnzymesIBA
01/2020 - 01/2018
3maleimideIBA
09/2018 - 01/2018
2Monoclonal AntibodiesIBA
01/2022 - 01/2021
2Peptides (Polypeptides)IBA
01/2022 - 11/2015
2SolutionsIBA
01/2022 - 09/2018
2Chloroquine (Aralen)FDA LinkGeneric
01/2021 - 01/2019
2LigandsIBA
01/2020 - 03/2019
2Oxygen (Dioxygen)IBA
01/2020 - 01/2019
2Glutathione (Reduced Glutathione)IBA
01/2020 - 01/2019
2Glucose (Dextrose)FDA LinkGeneric
01/2020 - 01/2019
2Surface-Active Agents (Surfactants)IBA
08/2019 - 05/2019
2Phosphotransferases (Kinase)IBA
01/2019 - 01/2017
2Disulfiram (Antabuse)FDA Link
05/2018 - 11/2015
2CopperIBA
05/2018 - 11/2015
1TeaIBA
11/2022
1cinnabarinic acidIBA
11/2022
1Proliferating Cell Nuclear Antigen (PCNA)IBA
06/2022
1ChromatinIBA
06/2022
1CalpainIBA
02/2022
1N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
02/2022
1TicagrelorIBA
01/2022
1Liposomes (Liposome)IBA
01/2022
1Therapeutic UsesIBA
01/2022
1Nitrous Oxide (Laughing Gas)IBA
01/2022
1Prostaglandins EIBA
01/2022
1Long Noncoding RNAIBA
01/2022
1Glutamine (L-Glutamine)FDA Link
01/2022
1IronIBA
01/2022
1FibrinIBA
01/2022
1Toll-Like Receptor AgonistsIBA
01/2022
1Type I DNA Topoisomerases (Topoisomerase I)IBA
01/2022
1Type II DNA Topoisomerases (Topoisomerase II)IBA
01/2022
1Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA
01/2022
1Fibrinolytic Agents (Antithrombotic Agents)IBA
01/2022
1MetalsIBA
01/2022
1Mitoxantrone (Novantrone)FDA LinkGeneric
01/2022
1Nanoparticle Drug Delivery SystemIBA
01/2022
1Cytarabine (Cytosar-U)FDA LinkGeneric
01/2022
1ProstaglandinsIBA
01/2022
1UracilIBA
01/2022
1NanogelsIBA
01/2022
1N-Me-Tyr1,D-Ala2,Asn8,Arg29-NHCH3-JI-38IBA
11/2021
1Growth Hormone-Releasing Hormone (Somatotropin Releasing Hormone)IBA
11/2021
1CalciumIBA
10/2021
1Digoxin (Digitek)FDA LinkGeneric
10/2021
1GinsenosidesIBA
10/2021
1phytochlorinIBA
08/2021

Therapy/Procedure

18Therapeutics
06/2022 - 11/2015
10Drug Therapy (Chemotherapy)
01/2022 - 05/2018
6Photochemotherapy (Photodynamic Therapy)
09/2020 - 11/2018
5Immunotherapy
01/2022 - 01/2020
3Lasers (Laser)
08/2021 - 11/2018
2Combination Drug Therapy (Combination Chemotherapy)
01/2022 - 10/2019
2Phototherapy (Light Therapy)
08/2021 - 09/2018
1Injections
01/2022
1Stem Cell Transplantation
10/2021
1Oral Administration
10/2021